CIKS Peptide
Code | Size | Price |
---|
PSI-2501P-0.05mg | 0.05mg | £166.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Human
Documents
Further Information
Additional Names:
ACT1, CIKS, C6orf2, C6orf4, C6orf5, C6orf6, CANDF8, PSORS13, Adapter protein CIKS, Nuclear factor NF-kappa-B activator 1, ACT1
Application Note:
CIKS peptide is used for blocking the activity of CIKS antibody.
Background References:
- Leonardi A, Chariot A, Claudio E, Cunningham K, Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA. 2000;97(19):10494-9.
- Asao H, Okuyama C, Kumaki S, et al. the common γ-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol. 2001;167(1):1-5.
- Vosshenrich CA, Di Santo JP. Cytokines: IL-21 joins the γ(c)-dependent network Curr Biol. 2001;11(5):R175-7.
Buffer:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Concentration:
200 ug/mL
NCBI Gene ID #:
10758
NCBI Official Name:
TRAF3 interacting protein 2
NCBI Official Symbol:
TRAF3IP2
NCBI Organism:
Homo sapiens
Peptide aa Location:
14 amino amino terminus of human CIKS.
Physical State:
Liquid
Protein Accession #:
AF274303
Protein GI Number:
10242289
Swissprot #:
O43734
Related Products
Product Name | Product Code | Supplier | CIKS Antibody | PSI-2501 | ProSci | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|